Numinus Wellness: Eight Capital Initiates With $1.10 Price Target

Last week, Eight Capital launched coverage on a basket of psychedelic companies. This comes after they produced an industry primer during the summer months. The fourth company initiated on this note is Numinus Wellness Inc. (TSXV: NUMI), with a C$1.10 12-month price target and buy rating while referring to the firm as “a diversified operator.”

They call Numinus the clear leader among the diversified players in the space as it has a number of different operations.

Eight Capital expects Numinus Wellness to do multiple accretive acquisitions to bolster its leading position. They expect Numinus to do acquisitions for new clinics into new jurisdictions, to which they will “bolt on” higher-margin psychotherapy services.

Silver47 Exploration Inc. — sponsored Sponsored · Silver47 Exploration Inc.

They also expect that Numinus will leverage its position as a supplier of naturally derived psilocybin and its extraction/purification expertise to develop capsules for human use in clinical trials. This potentially means they will have replacements to alternate forms for the supply of psilocybin.

Eight Capital also believes that Numinus is the perfect commercialization partner for other companies, saying, “we believe Numinus’ differentiated capabilities in developing, testing, and administering psychedelics in a clinical setting render it well-positioned to serve as a commercialization partner that could see its psychedelic-assisted therapy regiment differentiated from the offerings of other PAP clinics.”

Below you can see Eight Capital’s catalysts they are watching.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Is Agnico Eagle Seabridge Gold’s Mystery Lender?

This Gold Giant Is Building 1.5 Million More Ounces a Year | Agnico Eagle Q3 Earnings

This Gold Giant Was a Mess. Now It’s Back! | Barrick Mining Q3 2026 Earnings

Recommended

Epic Gold Delivers Maiden 279,000 Ounce Inferred Resource at Wilson Project

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Related News

Tilray: Canaccord Lowers Target On Expected Adult-Use Sales Slump, Revised Hexo Deal

Earlier this week, Tilray Brands (TSX: TLRY) announced an update to their strategic alliance with...

Friday, June 17, 2022, 10:49:29 AM

Canadian Cannabis: Canaccord Lifts Cronos Target, Reiterates Canopy Growth And Tilray Ratings

Yesterday Canaccord Genuity Capital Markets put out a second-quarter preview note on the top Canadian...

Thursday, July 28, 2022, 03:02:00 PM

Target: Analyst Consensus First Quarter Estimates

Target Corporation (NYSE: TGT) will be reporting their first-quarter financial results May 19th before market...

Tuesday, May 18, 2021, 06:29:00 PM

Canaccord: The Bottom For Gold Is Near

Canaccord Genuity Capital Markets on Monday issued an industry update on precious metals, where they...

Saturday, November 19, 2022, 01:29:00 PM

GoGold: BMO Lowers Target Price After Production Miss

On January 5th, GoGold Resources Inc. (TSX: GGD) announced its production data for the fiscal...

Friday, January 7, 2022, 02:49:00 PM